Hengfen Dai

发表

Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from China

M. Zhang, Shuyin Wu, Nianxu Huang, 2022, Cardiovascular Drugs and Therapy.

Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trials

Caiyun Zheng, Yan Chen, Hengfen Dai, 2021, Cardiovascular Diabetology.

Effect of Sodium-Glucose Cotransporter Type 2 Inhibitors on Clinical Outcomes in Patients With Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials

Caiyun Zheng, Yan Chen, Hengfen Dai, 2021 .

Use of Sacubitril/Valsartan in a Chronic Heart Failure Patient with Reduced Ejection Fraction Accompany Dilated Cardiomyopathy and Myocardial Indensification: A Case Report

Hengfen Dai, Yan Zhang, Jingwen Xiao, 2020 .

Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: A new evidence of Asian dose.

M. Zhang, Jun Su, Nianxu Huang, 2022, International journal of cardiology.

hsa-miR-4443 inhibits myocardial fibroblast proliferation by targeting THBS1 to regulate TGF-β1/α-SMA/collagen signaling in atrial fibrillation

Yuan Tang, Hengfen Dai, Yu OuYang, 2021, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known

Caiyun Zheng, Hengfen Dai, Meimei Lin, 2023, Hepatology communications.

Blockade of BDNF signalling attenuates chronic visceral hypersensitivity in an IBS‐like rat model

Hengfen Dai, Ying Tang, Yu Chen, 2020, European journal of pain.

MiRNA-1202 promotes the TGF-β1-induced proliferation, differentiation and collagen production of cardiac fibroblasts by targeting nNOS

Yuan Tang, Hengfen Dai, Yu OuYang, 2021, PloS one.

Zeta Inhibitory Peptide as a Novel Therapy to Control Chronic Visceral Hypersensitivity in a Rat Model

Y. Huang, Ying Tang, Hengfen Dai, 2016, PloS one.

Correction: Technology-Based Interventions in Oral Anticoagulation Management: Meta-Analysis of Randomized Controlled Trials

Hong Zhang, Caiyun Zheng, Hengfen Dai, 2020, Journal of medical Internet research.

Technology-Based Interventions in Oral Anticoagulation Management: Meta-Analysis of Randomized Controlled Trials

Hong Zhang, Caiyun Zheng, Hengfen Dai, 2020, Journal of medical Internet research.

New score for predicting major bleeding in patients with atrial fibrillation using direct oral anticoagulants.

M. Zhang, Nianxu Huang, Xia Chen, 2023, International journal of cardiology.

Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study

Min Zhang, Feilong Zhang, Shuyin Wu, 2023, Thrombosis Journal.

Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation Combined With Hypertension: A Multicenter, Retrospective Cohort Study

M. Zhang, Nianxu Huang, Xia Chen, 2023, Journal of clinical pharmacology.

Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study

Shuyin Wu, Nianxu Huang, Xia Chen, 2023, Thrombosis Journal.

Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from China

M. Zhang, Shuyin Wu, Nianxu Huang, 2022, Cardiovascular Drugs and Therapy.